DE69230146D1 - Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung - Google Patents

Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung

Info

Publication number
DE69230146D1
DE69230146D1 DE69230146T DE69230146T DE69230146D1 DE 69230146 D1 DE69230146 D1 DE 69230146D1 DE 69230146 T DE69230146 T DE 69230146T DE 69230146 T DE69230146 T DE 69230146T DE 69230146 D1 DE69230146 D1 DE 69230146D1
Authority
DE
Germany
Prior art keywords
monoclonal antibodies
proteins
antibodies against
putative hcv
against putative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69230146T
Other languages
English (en)
Other versions
DE69230146T2 (de
Inventor
Smriti Mehta
Jill Johnson
Stephen Dailey
Suresh Desai
Sushil Devare
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69230146D1 publication Critical patent/DE69230146D1/de
Publication of DE69230146T2 publication Critical patent/DE69230146T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69230146T 1991-08-21 1992-08-21 Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung Expired - Fee Related DE69230146T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/748,292 US5308750A (en) 1989-12-22 1991-08-21 Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
PCT/US1992/007189 WO1993004205A1 (en) 1991-08-21 1992-08-21 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same

Publications (2)

Publication Number Publication Date
DE69230146D1 true DE69230146D1 (de) 1999-11-18
DE69230146T2 DE69230146T2 (de) 2000-05-25

Family

ID=25008836

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230146T Expired - Fee Related DE69230146T2 (de) 1991-08-21 1992-08-21 Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung

Country Status (9)

Country Link
US (1) US5308750A (de)
EP (1) EP0603307B1 (de)
JP (1) JP3335351B2 (de)
AT (1) ATE185606T1 (de)
AU (1) AU2585092A (de)
CA (1) CA2115923A1 (de)
DE (1) DE69230146T2 (de)
ES (1) ES2139607T3 (de)
WO (1) WO1993004205A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273115B1 (de) * 1986-10-22 1994-09-07 Abbott Laboratories Chemilumineszierende Acridinium- und Phenantridiniumsalze
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6312889B1 (en) 1990-04-04 2001-11-06 Chiron Corporation Combinations of hepatitis c virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6274148B1 (en) * 1990-11-08 2001-08-14 Chiron Corporation Hepatitis C virus asialoglycoproteins
CA2129733C (en) * 1992-01-31 2006-10-31 James M. Casey Mammalian expression systems for hcv proteins
CA2162557C (en) 1993-05-12 2004-09-28 Amy J. Weiner Conserved motif of hepatitis c virus e2/ns1 region
US5824507A (en) * 1994-05-20 1998-10-20 Genelabs Technologies, Inc. Hepatitis G virus and molecular cloning thereof
JP3217600B2 (ja) * 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
EP1211315A1 (de) * 1994-07-29 2002-06-05 Innogenetics N.V. Rekombinante Vektoren zur Herstellung von HCV Hüllproteinen
US20040185061A1 (en) * 1994-07-29 2004-09-23 Innogenetics N.V. Redox reversible HCV proteins with native-like conformation
CN1044384C (zh) * 1994-08-25 1999-07-28 中国药品生物制品检定所 抗丙型肝炎病毒抗原单克隆抗体细胞株建立及其单克隆抗体
GB9517926D0 (en) 1995-09-01 1995-11-01 Biocine Spa Binding protein
US6747136B2 (en) * 1996-04-19 2004-06-08 Karolinska Innovations Ab Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
US6538114B1 (en) 1996-04-19 2003-03-25 Karolina Innovations Ab Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
JPH10136990A (ja) * 1996-09-18 1998-05-26 Boehringer Mannheim Gmbh Ｇ型肝炎ウイルスに対する抗体、ｈｇｖの診断検出のた めのおよび治療薬としてのその使用
GB9624165D0 (en) * 1996-11-19 1997-01-08 Amdex A S Use of nucleic acids bound to carrier macromolecules
EP0947525A1 (de) 1998-03-27 1999-10-06 Innogenetics N.V. Epitope in der viralen Hüllproteine und spezifische Antikörper gegen diese Epitope: Verwendung für die detektion von viralantigene im empfängergewebe
US7108855B2 (en) * 1998-06-24 2006-09-19 Innogenetics N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
US7091324B2 (en) * 1998-11-05 2006-08-15 Board Of Trustees Of Leland Stanford Junior University Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes
CA2380777C (en) * 1999-07-28 2011-01-04 Chiron Corporation Hepatitis c viral antigen immunoassay detection systems
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
WO2002036833A1 (en) * 2000-11-06 2002-05-10 Bio-Tech Imaging, Inc. Method and kits for detecting hepatitis infected cells
AU2002243259B2 (en) * 2000-12-01 2008-02-07 The Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services Monoclonal antibodies specific for the E2 glycoprotein of hepatitis C virus and their use in the diagnosis, treatment, and prevention of hepatitis C
US7101561B2 (en) 2000-12-01 2006-09-05 Innogenetics N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
GB0112652D0 (en) * 2001-05-24 2001-07-18 Inst Of Molecul & Cell Biology Internalisation of virus into cells
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
NZ579706A (en) 2007-02-21 2012-03-30 Univ Massachusetts Human antibodues against hepatitis C virus (HCV) E2 protein and uses thereof
US20080227111A1 (en) * 2007-03-16 2008-09-18 Sysmex Corporation Reagent kit and method for measuring hcv antibody
EP2201023A2 (de) * 2007-09-14 2010-06-30 GENimmune N.V. Affinitäts-tag
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227011A (en) * 1987-11-18 1992-03-26 Chiron Corp Non-a, non-b-hepatitis (hepatitis c) antigens, proteins, nucleotide sequences, vaccines and kits
HUT54896A (en) * 1989-03-17 1991-04-29 Chiron Corp Process for producing aquous diagnosticum and vaccine of nanbv
AU638304B2 (en) * 1989-12-22 1993-06-24 Abbott Laboratories Hepatitis c assay
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
EP0464287A1 (de) * 1990-06-25 1992-01-08 The Research Foundation for Microbial Diseases of Osaka University Non-A, Non-B Hepatitis Virus genomisches DNS und Antigenpolypeptide
CA2047792C (en) * 1990-07-26 2002-07-02 Chang Y. Wang Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
CA2049679C (en) * 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens

Also Published As

Publication number Publication date
EP0603307A1 (de) 1994-06-29
EP0603307B1 (de) 1999-10-13
CA2115923A1 (en) 1993-03-04
JPH06510192A (ja) 1994-11-17
JP3335351B2 (ja) 2002-10-15
DE69230146T2 (de) 2000-05-25
AU2585092A (en) 1993-03-16
ES2139607T3 (es) 2000-02-16
US5308750A (en) 1994-05-03
EP0603307A4 (de) 1995-01-18
WO1993004205A1 (en) 1993-03-04
ATE185606T1 (de) 1999-10-15

Similar Documents

Publication Publication Date Title
DE69230146D1 (de) Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung
DK0765478T3 (da) Positiv og positiv/negativ celleselektion medieret af peptidfrigørelse
ATE171472T1 (de) Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4
DK261386A (da) Monoklonale antistoffer
FI20021626A (fi) Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi
DK1232392T3 (da) Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring
ATE459706T1 (de) Monoklonales antikörper gegen das hcv kernantigen
HK1045729A1 (en) Early detection of flavivviruses using the ns1 glycoprotein.
DE69225960D1 (de) Monoklonale antikörper gegen mögliche hcv-hüllregionen und methoden diese zu benutzen
DE69224134D1 (de) Monoklonale Antikörper gegen Hepatitis-C-Virus
ATE202117T1 (de) Angiotensin ii rezeptor typ i spezifische monoklonale antikörper und hybridoma
BR0314166B8 (pt) teste de hcv
CA2095735A1 (en) Monoclonal antibodies to hepatitis c virus and method for using same
DE69227776D1 (de) Monoklonale antikörper gegen mutmassliche hepatitis c-virus ns5-proteine und ihre anwendungsmethoden
ATE294237T1 (de) S?ugetier thymokingene
DE60029570D1 (de) Verfahren zur isolierung der cd8+-zellen, und entsprechende hybridomazellen, antikörper und polypeptide
KR900700135A (ko) 광견병 비루스 세포를 특이적으로 인지하는 사람 모노클로날 항체, 이의 생성세포, 그 항체를 함유하는 제제 및 이들의 제조방법
BR0204612C1 (pt) anticorpos monoclonais antinúcleo de hcv
AR037216A1 (es) Anticuerpos monoclonales antinucleares de hcv
MX9703956A (es) Genes purificados que codifican antigenos de superficie de celulas de mamiferos; proteinas y anticuerpos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee